|
Post-op Prednisone and Glucose Monitoring in TKA
RECRUITINGPhase 4Sponsored by Columbia University
Actively Recruiting
PhasePhase 4
SponsorColumbia University
Started2026-06-22
Est. completion2027-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07630896
Summary
This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.
Eligibility
Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria: * MUST BE CONTACTED BY THE STUDY TEAM TO BE PART OF THE STUDY. No applications taken * Undergoing Primary Unicompartmental Knee Arthroplasty or Total Hip Arthroplasty * Age 18 and above * Patient at Columbia University Irving Medical Center and be undergoing planned surgery by Dr. Roshan P. Shah Exclusion Criteria: * Steroid therapy * Narcotic use within past 3 months * History of corticosteroid intolerance * Pregnancy * Uncontrolled diabetes * Doesn't own smart phone Drop Criteria: \- 2nd dose of IV dexamethasone
Conditions4
ArthritisOsteoarthritisTotal Hip Arthroplasty (THA)Unicompartmental Knee Arthroplasty
Interventions1
Locations1 site
Find trials near these locations
Related trials
- A Phase II Study of Durvalumab Treatment - Substudy A: In Patients Who Discontinued Prior Checkpoint Therapy Due to Immune Related Toxicity - Substudy B: For Continued Treatment (+/- Tremelimumab) of Patients Previously Enrolled to Completed CCTG Studies — Canadian Cancer Trials Group
- A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL — Ruijin Hospital
- A Study of HDM2005 in Combination With Standard of Care in Patients With Diffuse Large B-Cell Lymphoma — Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
- A Study of JNJ-95566692 in Participants With Non-Hodgkin Lymphoid Malignancies — Janssen Research & Development, LLC
- A Study of Risvutatug Rezetecan in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) [EMBOLD Prostate-302] — GlaxoSmithKline
- A Study to Evaluate the Safety and Drug Levels of ASP5541 in Chinese Participants With Prostate Cancer — Astellas Pharma Global Development, Inc.
- Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in Brazil — Instituto do Cancer do Estado de São Paulo
- Chidamide Combination With R-mini CHOP Followed by Chidamide+CD20 Maintenance in Elderly Newly Diagnosed MYC/BCL2+ DLBCL — Ou Bai, MD/PHD
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 4
SponsorColumbia University
Started2026-06-22
Est. completion2027-12
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT07630896